- Esophageal Cancer Research and Treatment
- Esophageal and GI Pathology
- Metastasis and carcinoma case studies
- Gastric Cancer Management and Outcomes
- Dysphagia Assessment and Management
- Lung Cancer Diagnosis and Treatment
- Gastrointestinal Tumor Research and Treatment
- Tracheal and airway disorders
- Gastroesophageal reflux and treatments
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
- Occupational and environmental lung diseases
- Immune Response and Inflammation
- Neurofibromatosis and Schwannoma Cases
- Gastrointestinal disorders and treatments
- Sarcoma Diagnosis and Treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cardiac, Anesthesia and Surgical Outcomes
- RNA modifications and cancer
- Congenital Diaphragmatic Hernia Studies
- Colorectal and Anal Carcinomas
- Nutrition and Health in Aging
- Appendicitis Diagnosis and Management
- Multiple and Secondary Primary Cancers
- IL-33, ST2, and ILC Pathways
Suwa Red Cross Hospital
2012-2023
Akita University Hospital
2017
Akita University
1999-2012
Iwate Prefectural Central Hospital
2007
Heat shock protein (Hsp) 90 is a key regulator of variety oncogene products and cell-signaling molecules, the therapeutic benefit its inhibition in combination with radiation or chemotherapy has been investigated. In addition, hyperthermia used for many years to treat various malignant tumors. We previously described system which was induced using thermosensitive ferromagnetic particles (FMP) Curie temperature (Tc = 43 degrees C) low enough mediate automatic control, demonstrated antitumor...
Hyperthermia has been used for many years to treat a variety of malignant tumors. The Curie temperature (Tc) is transition point at which magnetic materials lose their properties, causing cessation current and thus heat production. Tc enables automatic control throughout tumor as result the self‐regulating nature thermosensitive material. We have developed method magnetically‐induced hyperthermia using ferromagnetic particles (FMPs) with low (43°C), enough mediate control. B16 melanoma cells...
Pulmonary edema is the most frequent postoperative complication following esophagectomy for thoracic esophageal cancer. We enrolled 23 patients who underwent with extended lymph node dissection cancer in a prospective observational clinical trial. used PiCCO device to measure extravascular lung water aim of determining whether it correlates respiratory index and predictive pulmonary complications. Based on constant criteria, tracheal tubes 11 were removed morning day 1 (extubation group),...
Identification of reliable markers chemo- and radiosensitivity the key molecules that enhance susceptibility squamous esophageal cancer cells to anticancer treatments would be highly desirable. To test whether regenerating gene (REG) I expression enhances in cell carcinoma cells, we used MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assays compare radiosensitivities untransfected TE-5 TE-9 with those stably transfected REG Ialpha Ibeta. We then flow cytometry determine...
We investigated the effectiveness of chemoradiotherapy for treatment lymph node recurrence and hematogenous metastasis after esophagectomy esophageal squamous cell carcinoma. Between 2001 2006, 216 patients with thoracic carcinoma had curative esophagectomy. Of those, 23 received (50.0–68.8 Gy). In addition, five isolated recurrences in a distant organ (50.0–60.0 analyzed outcomes from radiotherapy recurrent cancer. The 1-, 2-, 5-year survival rates whose was treated were 52, 31, 24%,...
C-reactive protein to albumin ratio (CAR) has been utilized as a prognostic factor in various carcinomas. We investigated the relationship between preoperative, postoperative day (POD) 1, and POD 7 CARs prognosis of patients with colorectal cancer (CRC).Three hundred twenty CRC who underwent laparoscopic radical resection May 2011 December 2016 were enrolled. Patients selected into 2 groups, high CAR low (n=72/group), based on CARs. The relapse-free survival (RFS) overall (OS) compared...